Analyst Ratings for Denali Therapeutics Inc. (DNLI)

DNLI Rating Summary

DNLI Price Target Summary

* Over Last 12-Mos
  |   Expand Research on DNLI
Overall Rating: BUY   Rating Trend: Up   Avg. $ Target: $77.25 (+149.8%) * Over Last 12-Mos
Rating Score: 8.1 / 10   Percentile Rank: 83%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
6/23/2022 Berenberg Caroline Palomeque New Coverage Buy
(N/A)
39.00
(N/A)
27.21
(30.93)
13.67% Details
12/10/2021 Raymond James Danielle Brill New Coverage Market Perform
(N/A)
N/A
(N/A)
46.16
(30.93)
-32.99% Details
Like DNLI Ratings? Also take a look at SANA, MCRB, RUBY, MRNA

DNLI Ratings News